Imaging

We will extend the role of existing techniques and develop novel technologies. These will include

1. novel molecular imaging agents for tissue function and metabolism using conventional 1H based MR, 13C hyperpolarised methodologies as well as optical and radionuclide methods,

 

2. extend the diagnostic role of conventional whole body MRI systems and perform studies to demonstrate where MR could eventually replace many more X-ray procedures,

 

3. develop and validate quantitative imaging methods for monitoring disease progress and the effects of therapeutic interventions in a wide range of specialties, particularly oncology, cardiology, gastroenterology, metabolic science and neuroscience, and

 

4. refinement and development of imaging techniques for the neurologically impaired.